Frontlight ResearchEarly access
Trial site
Tokyo Yamate Medical Center
- 4running trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease2 trials
- Ulcerative colitis2 trials
- Phase
- Phase 22 trials
- Phase 32 trials
- Status
- Active, not recruiting2 trials
- Recruiting2 trials
- Lead sponsor
- Eli Lilly and Company3 trials
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 trial
Running trials
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease1 recruiting
- Ulcerative colitis1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026